Drug recall D-0623-2021
Product
Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, SAMPLE, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-2911-90 (Pen) NDC 0169-2911-97 (Kit)
Reason for recall
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Lots and codes
JP54291, exp 06/20/2021
Recall details
- Recalling firm
- Novo Nordisk Inc, Plainsboro, NJ
- Quantity
- N/A
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 22, 2021
- Terminated
- December 9, 2022
Related products
- Xultophy 100/3.6 – drug information
- NDC 0169-2911 Xultophy 100/3.6 · Insulin Degludec 100 [iU]/mL; Liraglutide 3.6 mg/mL · Novo Nordisk